Bank of America’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-912,332
| Closed | -$47.9M | – | 7618 |
|
|
2020
Q3 | $47.9M | Buy |
912,332
+730,058
| +401% | +$30.2M | 0.01% | 1106 |
|
|
2020
Q2 | $6.06M | Sell |
182,274
-22,067
| -11% | -$703K | ﹤0.01% | 2678 |
|
|
2020
Q1 | $5.56M | Buy |
204,341
+25,873
| +14% | +$720K | ﹤0.01% | 2579 |
|
|
2019
Q4 | $3.52M | Buy |
178,468
+2,139
| +1% | +$34.2K | ﹤0.01% | 3550 |
|
|
2019
Q3 | $2.29M | Sell |
176,329
-1,453
| -0.8% | -$17.5K | ﹤0.01% | 3935 |
|
|
2019
Q2 | $2.21M | Buy |
177,782
+61,579
| +53% | +$818K | ﹤0.01% | 3973 |
|
|
2019
Q1 | $1.69M | Buy |
116,203
+53,694
| +86% | +$686K | ﹤0.01% | 4122 |
|
|
2018
Q4 | $690K | Sell |
62,509
-169,899
| -73% | -$2.36M | ﹤0.01% | 4703 |
|
|
2018
Q3 | $6.11M | Sell |
232,408
-72,537
| -24% | -$1.96M | ﹤0.01% | 2993 |
|
|
2018
Q2 | $6.24M | Buy |
304,945
+56,187
| +23% | +$1.21M | ﹤0.01% | 2924 |
|
|
2018
Q1 | $4.51M | Sell |
248,758
-51,025
| -17% | -$851K | ﹤0.01% | 3179 |
|
|
2017
Q4 | $4.18M | Sell |
299,783
-621,376
| -67% | -$8.4M | ﹤0.01% | 3289 |
|
|
2017
Q3 | $17M | Buy |
921,159
+147,144
| +19% | +$2.46M | ﹤0.01% | 2008 |
|
|
2017
Q2 | $13.1M | Sell |
774,015
-6,984
| -0.9% | -$106K | ﹤0.01% | 2108 |
|
|
2017
Q1 | $10.4M | Sell |
780,999
-6,200
| -0.8% | -$97.1K | ﹤0.01% | 2340 |
|
|
2016
Q4 | $11.8M | Buy |
787,199
+15,314
| +2% | +$202K | ﹤0.01% | 2161 |
|
|
2016
Q3 | $9.02M | Sell |
771,885
-26,910
| -3% | -$316K | ﹤0.01% | 2322 |
|
|
2016
Q2 | $8.63M | Sell |
798,795
-38,181
| -5% | -$394K | ﹤0.01% | 2326 |
|
|
2016
Q1 | $7.73M | Buy |
836,976
+128,626
| +18% | +$1.38M | ﹤0.01% | 2387 |
|
|
2015
Q4 | $10.5M | Buy |
708,350
+13,644
| +2% | +$228K | ﹤0.01% | 2218 |
|
|
2015
Q3 | $11.4M | Buy |
694,706
+259,540
| +60% | +$5.31M | ﹤0.01% | 2096 |
|
|
2015
Q2 | $9.93M | Buy |
435,166
+195,633
| +82% | +$3.9M | ﹤0.01% | 1938 |
|
|
2015
Q1 | $3.64M | Buy |
239,533
+44,559
| +23% | +$579K | ﹤0.01% | 2743 |
|
|
2014
Q4 | $2.35M | Sell |
194,974
-36,712
| -16% | -$420K | ﹤0.01% | 3227 |
|
|
2014
Q3 | $2.63M | Buy |
231,686
+2,866
| +1% | +$32.7K | ﹤0.01% | 3135 |
|
|
2014
Q2 | $2.76M | Buy |
228,820
+192,303
| +527% | +$2.27M | ﹤0.01% | 3087 |
|
|
2014
Q1 | $426K | Sell |
36,517
-10,265
| -22% | -$174K | ﹤0.01% | 4754 |
|
|
2013
Q4 | $827K | Sell |
46,782
-18,503
| -28% | -$311K | ﹤0.01% | 4280 |
|
|
2013
Q3 | $939K | Sell |
65,285
-130,551
| -67% | -$2M | ﹤0.01% | 4005 |
|
|
2013
Q2 | $2.95M | Buy |
+195,836
| New | +$2.58M | ﹤0.01% | 2786 |
|
Bank of America's MNTA Position: Q4 2020 in Review
Bank of America sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 912,332 shares — an estimated $47.9M sold.
Bank of America first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $47.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Bank of America reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Bank of America sold 912,332 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $47.9M.
- Bank of America first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Bank of America's Momenta Pharmaceuticals, Inc. position peaked at $47.9M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.